HealthTech and MedTech Thought Leadership from Nelson Advisors

top of page

Nelson Advisors > European HealthTech & MedTech

Nelson Advisors Big Questions in HealthTech Series: Will NHS reform make the UK investable again?

Nelson Advisors Big Questions in HealthTech Series: Will NHS reform make the UK investable again?

Nelson Advisors Big Questions in HealthTech Series: Will NHS reform make the UK investable again?

Nelson Advisors

28 minutes ago

Nelson Advisors Big Questions in HealthTech Series: Is Venture Capital right for MedTech? Should more European MedTech be funded by debt, royalties or strategics from day one?

Nelson Advisors Big Questions in HealthTech Series: Is Venture Capital right for MedTech? Should more European MedTech be funded by debt, royalties or strategics from day one?

Nelson Advisors Big Questions in HealthTech Series: Is Venture Capital right for MedTech? Should more European MedTech be funded by debt, royalties or strategics from day one?

Nelson Advisors

1 hour ago

Nelson Advisors Big Questions in HealthTech Series: Is the EU AI Act a moat or a millstone?

Nelson Advisors Big Questions in HealthTech Series: Is the EU AI Act a moat or a millstone?

Nelson Advisors Big Questions in HealthTech Series: Is the EU AI Act a moat or a millstone?

Nelson Advisors

1 day ago

Nelson Advisors Big Questions in HealthTech Series: What is Clinical AI actually worth?

Nelson Advisors Big Questions in HealthTech Series: What is Clinical AI actually worth?

Nelson Advisors Big Questions in HealthTech Series: What is Clinical AI actually worth?

Nelson Advisors

1 day ago

Nelson Advisors Big Questions in HealthTech Series: Is the LLM an interface or the decision maker?

Nelson Advisors Big Questions in HealthTech Series: Is the LLM an interface or the decision maker?

Nelson Advisors Big Questions in HealthTech Series: Is the LLM an interface or the decision maker?

Nelson Advisors

4 days ago

This Week in European MedTech and HealthTech: 3rd July 2026

This Week in European MedTech and HealthTech: 3rd July 2026

This Week in European MedTech and HealthTech: 3rd July 2026

Nelson Advisors

4 days ago

Halfway through 2026, Nelson Advisors predictions on what’s to come in European HealthTech and MedTech

Halfway through 2026, Nelson Advisors predictions on what’s to come in European HealthTech and MedTech

Halfway through 2026, Nelson Advisors predictions on what’s to come in European HealthTech and MedTech

Nelson Advisors

6 days ago

The Paradigm Shift in European Healthcare M&A Advisory

The Paradigm Shift in European Healthcare M&A Advisory

The Paradigm Shift in European Healthcare M&A Advisory

Nelson Advisors

6 days ago

The Invisible Infrastructure of Healthcare: Mapping the Socio Technical Architecture and Governance Risks of Shadow AI

The Invisible Infrastructure of Healthcare: Mapping the Socio Technical Architecture and Governance Risks of Shadow AI

The Invisible Infrastructure of Healthcare: Mapping the Socio Technical Architecture and Governance Risks of Shadow AI

Nelson Advisors

6 days ago

The Regulatory Realignment of Omnibus VII: Implications for European HealthTech and MedTech

The Regulatory Realignment of Omnibus VII: Implications for European HealthTech and MedTech

The Regulatory Realignment of Omnibus VII: Implications for European HealthTech and MedTech

Nelson Advisors

6 days ago

The Nelson Advisors Guide for Founders to HealthTech and MedTech Success in 2026: 10 European Case Studies

The Nelson Advisors Guide for Founders to HealthTech and MedTech Success in 2026: 10 European Case Studies

The Nelson Advisors Guide for Founders to HealthTech and MedTech Success in 2026: 10 European Case Studies

Nelson Advisors

Jun 28

Scaling Healthcare Innovation: Life Sciences, MedTech and HealthTech Success Stories from the Goldman Sachs 10,000 Small Businesses UK Programme

Scaling Healthcare Innovation: Life Sciences, MedTech and HealthTech Success Stories from the Goldman Sachs 10,000 Small Businesses UK Programme

Scaling Healthcare Innovation: Life Sciences, MedTech and HealthTech Success Stories from the Goldman Sachs 10,000 Small Businesses UK Programme #10KSBUK

Nelson Advisors

Jun 28

Beyond the Prescription Pad: The Strategic Convergence of Consumer Technology, Retail Infrastructure and Preventive Healthcare

Beyond the Prescription Pad: The Strategic Convergence of Consumer Technology, Retail Infrastructure and Preventive Healthcare

Beyond the Prescription Pad: The Strategic Convergence of Consumer Technology, Retail Infrastructure and Preventive Healthcare

Nelson Advisors

Jun 27

Passive Continuous Phenotyping and Remote Therapeutic Monitoring: The ŌURA Integration Framework

Passive Continuous Phenotyping and Remote Therapeutic Monitoring: The ŌURA Integration Framework

Passive Continuous Phenotyping and Remote Therapeutic Monitoring: The ŌURA Integration Framework

Nelson Advisors

Jun 27

Strategic Reconfiguration of Global Healthcare: Analysing Prosus’s €400 Million Investment in Alan and the Broader Naspers AI Ecosystem Moat

Strategic Reconfiguration of Global Healthcare: Analysing Prosus’s €400 Million Investment in Alan and the Broader Naspers AI Ecosystem Moat

Strategic Reconfiguration of Global Healthcare: Analysing Prosus’s €400 Million Investment in Alan and the Broader Naspers AI Ecosystem Moat

Nelson Advisors

Jun 26

The Scaleup Europe Fund: Navigating Late-Stage Growth Capital Opportunities for European HealthTech and MedTech Companies

The Scaleup Europe Fund: Navigating Late-Stage Growth Capital Opportunities for European HealthTech and MedTech Companies

The Scaleup Europe Fund: Navigating Late Stage Growth Capital Opportunities for European HealthTech and MedTech Companies

Nelson Advisors

Jun 25

Venture to Venture M&A: Strategic Consolidation in European HealthTech and MedTech

Venture to Venture M&A: Strategic Consolidation in European HealthTech and MedTech

Venture to Venture M&A: Strategic Consolidation in European HealthTech and MedTech

Nelson Advisors

Jun 25

Digital Health IPO Landscape in 2026 and Exit Backlog Paradox

Digital Health IPO Landscape in 2026 and Exit Backlog Paradox

Digital Health IPO Landscape in 2026 and Exit Backlog Paradox

Nelson Advisors

Jun 24

The Structural Convergence of Care Management and Remote Monitoring: A Strategic Valuation of ChartSpan’s Acquisition of Validic

The Structural Convergence of Care Management and Remote Monitoring: A Strategic Valuation of ChartSpan’s Acquisition of Validic

The Structural Convergence of Care Management and Remote Monitoring: A Strategic Valuation of ChartSpan’s Acquisition of Validic

Nelson Advisors

Jun 23

The MedTech and HealthTech Corporate Divestiture landscape over the next 12 months

The MedTech and HealthTech Corporate Divestiture landscape over the next 12 months

The MedTech and HealthTech Corporate Divestiture landscape over the next 12 months

Nelson Advisors

Jun 22

bottom of page